(Q46703466)

24 December 2017

http://europepmc.org/abstract/MED/25273866

title

Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib (English)

1 reference

24 December 2017

http://europepmc.org/abstract/MED/25273866

main subject

lymphocyte

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

Romualdo Barroso-Sousa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Leonardo Gomes da Fonseca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Afonso da Silva Alves Bento

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Bruna Paccola Blanco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Gabriel Luis Valente

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Tulio Eduardo Flesch Pfiffer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Paulo Marcelo Hoff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Jorge Sabbaga

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

2 October 2014

1 reference

24 December 2017

http://europepmc.org/abstract/MED/25273866

published in

Medical Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12032-014-0264-5

4 June 2020

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0264-5

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25273866

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25273866

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-014-0264-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25273866%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference